| Literature DB >> 20594595 |
David Chiron1, Gaetan Jego, Catherine Pellat-Deuceunynck.
Abstract
Multiple Myeloma (MM) cells express and respond to a broad range of TLRs. Accumulating evidences suggest that TLRs act as double-edged sword in MM biology. Indeed, TLR9 or TLR3 ligands could enhance immunity against MM cells or directly induce cell apoptosis, whereas various TLR agonists could induce MM survival, proliferation, and immune escape. This review is focused on the heterogeneous expression and function of TLRs in MM and on the potential implication of TLR ligands of infectious or endogenous origin in MM emergence, resistance, or progression.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20594595 DOI: 10.1016/j.leukres.2010.06.002
Source DB: PubMed Journal: Leuk Res ISSN: 0145-2126 Impact factor: 3.156